Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Tabuchi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pharmacogenomics|August 12, 2009
Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model combined with Bayesian forecastingTomohiro Sasaki, Hiroko Tabuchi, Shun Higuchi, et al.
Clinical Pharmacology in Drug Development|June 6, 2018
Pharmacokinetics of Perampanel in Healthy Korean, White, and Japanese Adult SubjectsHiroko Tabuchi, Sari Shiba, Sanae Yasuda, et al.
Journal of Clinical Pharmacology|December 22, 2018
Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose StudyHiroko Tabuchi, Toshinori Katsurabara, Masahiko Mori, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pharmacogenomics|August 12, 2009
Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model combined with Bayesian forecastingTomohiro Sasaki, Hiroko Tabuchi, Shun Higuchi, et al.
Clinical Pharmacology in Drug Development|June 6, 2018
Pharmacokinetics of Perampanel in Healthy Korean, White, and Japanese Adult SubjectsHiroko Tabuchi, Sari Shiba, Sanae Yasuda, et al.
Journal of Clinical Pharmacology|December 22, 2018
Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose StudyHiroko Tabuchi, Toshinori Katsurabara, Masahiko Mori, et al.
Pageof 1